+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

HTG Molecular Diagnostics Inc (HTGM) - Product Pipeline Analysis, 2018 Update

  • ID: 4050689
  • Company Profile
  • 44 pages
  • GlobalData
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Diligent Corp
  • WidePoint Corp
  • MORE
Summary

HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems that provide quantitative gene expression analysis in formalin-fixed paraffin embedded tissue. HTG also offers endogenous control array, custom array development, qSelect miRNA gene list, qSelect mRNA gene list, qDiscovery miRNA Version 16, clinical trial support and ingenuity IPA data analysis services, among others. The company serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. HTG is headquartered in Tucson, Arizona, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company HTG Molecular Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Diligent Corp
  • WidePoint Corp
  • MORE
HTG Molecular Diagnostics Inc Company Overview
HTG Molecular Diagnostics Inc Company Snapshot
HTG Molecular Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
HTG Molecular Diagnostics Inc – Pipeline Analysis Overview
HTG Molecular Diagnostics Inc - Key Facts
HTG Molecular Diagnostics Inc - Major Products and Services
HTG Molecular Diagnostics Inc Pipeline Products by Development Stage
HTG Molecular Diagnostics Inc Pipeline Products Overview
Breast Cancer Recurrence Risk Score Test
Breast Cancer Recurrence Risk Score Test Product Overview
CNV Navigator
CNV Navigator Product Overview
Companion Diagnostic Test - B-Cell Malignancy
Companion Diagnostic Test - B-Cell Malignancy Product Overview
Companion Diagnostic Test - Tumor Inflammation
Companion Diagnostic Test - Tumor Inflammation Product Overview
COPD Risk Stratification Test
COPD Risk Stratification Test Product Overview
Diagnostic Test - Breast Cancer
Diagnostic Test - Breast Cancer Product Overview
Diagnostic Test - Lung Cancer
Diagnostic Test - Lung Cancer Product Overview
Diagnostic Test - Lymphoma
Diagnostic Test - Lymphoma Product Overview
Diagnostic Test - Melanoma
Diagnostic Test - Melanoma Product Overview
Fusion Navigator
Fusion Navigator Product Overview
Heart Transplant Rejection Blood Test
Heart Transplant Rejection Blood Test Product Overview
HTG EdgeSeq ALKPlus Assay
HTG EdgeSeq ALKPlus Assay Product Overview
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 Product Overview
HTG JANUS
HTG JANUS Product Overview
Hyper Progressor Test
Hyper Progressor Test Product Overview
I/O Suite
I/O Suite Product Overview
Ion PGM Dx System - Cancer Assay
Ion PGM Dx System - Cancer Assay Product Overview
Ion PGM Dx System - Genetic Disorder Assay
Ion PGM Dx System - Genetic Disorder Assay Product Overview
NGS-based Theranostic Tool
NGS-based Theranostic Tool Product Overview
HTG Molecular Diagnostics Inc - Key Competitors
HTG Molecular Diagnostics Inc - Key Employees
HTG Molecular Diagnostics Inc - Locations And Subsidiaries
Head Office
Recent Developments
HTG Molecular Diagnostics Inc, Recent Developments
May 10, 2018: HTG Molecular Diagnostics Reports First Quarter 2018 Results
Apr 16, 2018: HTG Promotes John Lubniewski to President and Chief Operating Officer
Apr 03, 2018: HTG Announces New Patent for Its Technology Issued in Japan
Mar 22, 2018: HTG Molecular Diagnostics Announces Fourth Quarter And Full Year 2017 Results
Feb 26, 2018: HTG Announces New Australian Patent for Its Technology
Jan 10, 2018: University laboratory at Discovery Park is playing key role in early cancer detection research
Jan 04, 2018: HTG Announces Preliminary Fourth Quarter and Full Year 2017 Unaudited Financial Results and Provides Initial 2018 Revenue Guidance
Nov 07, 2017: HTG Molecular Diagnostics Reports 2017 Third Quarter Earnings
Sep 20, 2017: HTG Announces Issuance of Two Method Patents Related to its Technology
Sep 18, 2017: HTG Molecular Diagnostics Receives ISO 13485 Certification for Health Canada CMDCAS Requirements
Appendix
Methodology
Contact Us
Disclaimer

List of Tables
HTG Molecular Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type
HTG Molecular Diagnostics Inc Pipeline Products by Indication
HTG Molecular Diagnostics Inc, Key Facts
HTG Molecular Diagnostics Inc, Major Products and Services
HTG Molecular Diagnostics Inc Number of Pipeline Products by Development Stage
HTG Molecular Diagnostics Inc Pipeline Products Summary by Development Stage
Breast Cancer Recurrence Risk Score Test - Product Status
Breast Cancer Recurrence Risk Score Test - Product Description
CNV Navigator - Product Status
CNV Navigator - Product Description
Companion Diagnostic Test - B-Cell Malignancy - Product Status
Companion Diagnostic Test - B-Cell Malignancy - Product Description
Companion Diagnostic Test - Tumor Inflammation - Product Status
Companion Diagnostic Test - Tumor Inflammation - Product Description
COPD Risk Stratification Test - Product Status
COPD Risk Stratification Test - Product Description
Diagnostic Test - Breast Cancer - Product Status
Diagnostic Test - Breast Cancer - Product Description
Diagnostic Test - Lung Cancer - Product Status
Diagnostic Test - Lung Cancer - Product Description
Diagnostic Test - Lymphoma - Product Status
Diagnostic Test - Lymphoma - Product Description
Diagnostic Test - Melanoma - Product Status
Diagnostic Test - Melanoma - Product Description
Fusion Navigator - Product Status
Fusion Navigator - Product Description
Heart Transplant Rejection Blood Test - Product Status
Heart Transplant Rejection Blood Test - Product Description
HTG EdgeSeq ALKPlus Assay - Product Status
HTG EdgeSeq ALKPlus Assay - Product Description
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Status
HTG EdgeSeq DLBCL Cell of Origin Companion Diagnostic Assay - M7583 - Product Description
HTG JANUS - Product Status
HTG JANUS - Product Description
Hyper Progressor Test - Product Status
Hyper Progressor Test - Product Description
I/O Suite - Product Status
I/O Suite - Product Description
Ion PGM Dx System - Cancer Assay - Product Status
Ion PGM Dx System - Cancer Assay - Product Description
Ion PGM Dx System - Genetic Disorder Assay - Product Status
Ion PGM Dx System - Genetic Disorder Assay - Product Description
NGS-based Theranostic Tool - Product Status
NGS-based Theranostic Tool - Product Description
HTG Molecular Diagnostics Inc, Key Employees
Glossary

List of Figures
HTG Molecular Diagnostics Inc Pipeline Products by Equipment Type
HTG Molecular Diagnostics Inc Pipeline Products by Development Stage
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • WidePoint Corp
  • Vertical Computer Systems Inc
  • Diligent Corp
Note: Product cover images may vary from those shown
Adroll
adroll